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Abstract Article Info 
Introduction: The survival rate of Nasopharyngeal carcinoma (NPC) patients is influenced by several 
prognostic factors, such as patient factors, tumor factors and therapeutic interventions carried out as well as the 
quality of care. Tumor factors in the form of spread of local invasion, regional lymphatic involvement and 
metastasis that is reflected in the TNM stage (Tumor, Nodule and Metastatic) are the most important prognostic 
factors of NPC. Study data on NPC prognostic factors is very important to develop better management while 
NPC prognostic factors are very different. 
Objective: To determine the prognostic factors that affected survival rate of nasopharyngeal carcinoma patients. 
Material and methods: Analytic observational study with particular design of survival analysis. Data was taken 
from medical records and then performed survival analysis on the studied factors. Factors investigated in this 
study are age, sex, staging, T size, N size, Metastasis, WHO classification and treatment. Sample of this study 
were all patients who were initially diagnosed with NPC in RSUP. Dr. Mohammad Hoesin Palembang from 
January 2013 until December 2013. A total of 52 patients fulfilled the inclusion and exclusion criteria.  
Results: From a total of 52 patients, 50% died and 50% survived. Survival was worse in the 30-39 year age 
group (30.8%), male sex (47.2%), Stage IV (44.4%), T4 size (40%), N1 size (23,1%), Distant metastases (40%), 
WHO type III (48.5%), and chemoradiation (48.9%). In multivariate analysis, it was found that the variables 
that most influenced the survival of NPC patients based on P <0.05 and based on hazard ratio strength were T-
size, N-size categories and Metastasis with 95% CI.  
Conclusion: Prognostic factors that affected the survival of NPC patients in RSUP. Dr. Mohammad Hoesin 
Palembang are T size, N size, and Metastasis. 
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1. INTRODUCTION 
Nasopharyngeal carcinoma (NPC) is a malignant tumor that grows in 
the nasopharyngeal area with predilection in the fossa Rossenmuller and 
nasopharyngeal roof, which is a transitional area of the cuboidal epithelium 
transforms into a squamous epithelium [1]. Based on a report from the 
Global Burden of Cancer (GLOBOCAN) in 2012, there were 87,000 new 
cases of nasopharyngeal carcinoma that appeared annually (61,000 new 
cases of men and 26,000 new cases of women), out of 51,000 deaths due to 
nasopharyngeal carcinoma (36,000 men and 15,000 female). The incidence 
of nasopharyngeal carcinoma in Indonesia turns out to be quite high, which 
is about 4.7 new cases per year per 100,000 population or estimated at 
around 7000-8000 cases per year in Indonesia [2]. Data in O.R.L.H.N.S. 
Medical Faculty Universitas Indonesia RSCM in 2013 to 2016 showed 506 
cases [3]. Data in O.R.L.H.N.S. Medical Faculty Universitas Sriwijaya 
RSMH in 2013 to 2017 showed 284 cases. 
The prognosis of NPC is affected by several factors including tumor 
factors, patient factors and therapeutic interventions carried out as well as 
the quality of care. Tumor factors such as spread of local invasion, regional 
lymphatic involvement and metastasis reflected in the TNM stage (tumor, 
node and Metastatic) are the most important prognostic factors of NPC. In 
general, advanced T size is associated with poor local control and survival 
rates, advanced N size increases the risk of distant metastases and patients 
with distant metastases usually have low survival rate. The histopathological 
classification of NPC based on the World Health Organization (WHO) also 
influences the prognosis. Patient factors are age and gender. Therapeutic 
interventions consisting of radiotherapy, chemotherapy and 
chemoradiotherapy are included in the prognostic factor, concurrent 
chemoradiation at an advanced local stage has a better prognosis than 
radiotherapy alone. The quality of care in the form of providing care for 
NPC patients with comorbidities such as performance status, anemia and 
nutritional status also affects the prognosis. Performance status was assessed 
using ECOG (Eastern Cooperative Oncology Group) scores [4]. Decreased 
hemoglobin levels will cause tumor hypoxia and increased hypoxic cells, 
thereby affecting the effectiveness of radiotherapy. Nutritional status with 
weight loss of more than 10% has a local control of 5 years 85.6% compared 
to 90.9% in patients with weight loss of less than 10% [5]. 
Survival is the percentage of individuals living in a group with a certain 
disease in a specified period. The overall survival period can be assessed 
with a survival period of 2 years, 5 years or 10 years [6]. Medical studies 
often used survival as a method in assessing the effectiveness of treatments 
that can affect the prognosis and survival rate [7]. Overall survival is the 
gold standard in evaluating the outcome of treatments carried out in the field 
of oncology but does not directly measure the benefits of treatment and the 
cause of death for individuals [8]. Survival was analyzed by a particular 
design that is using survival analysis. The survival rate of NPC is affected 
by several prognostic factors, such as patient factors, tumor factors and 
therapeutic interventions carried out as well as the quality of care. In a 
retrospective study by Wu et al (2017), 10-years survival rate in NPC 
patients receiving radiotherapy was 100%, 87.1%, 75.5% and 55.6% for 
stages I, II, III and IV respectively [8]. According to the 2010 AJCC, 5-years 
relative survival rate in patients with Stage I to IV NPC in a sequence of 
72%, 64%, 62%, and 38% [9]. 
Study data on NPC prognostic factors is very important to develop 
better management while NPC prognostic factors are very different. Study 
on the prognostic factors of NPC in RSUP. Dr. Mohammad Hoesin has never 
been done and data regarding the survival rate of NPC patients is not 
available, while NPC cases in RSUP. Dr. Mohammad Hoesin are quite high. 
This study was intended to determine the prognostic factors that affect the 
survival rate of nasopharyngeal carcinoma patients in RSUP. Dr. 
Mohammad Hoesin Palembang. 
2. MATERIAL AND METHODS 
This study is an observational analytic study with a particular design of 
survival analysis. The study sample was all patients who were first 
diagnosed with NPC from January 2013 until December 2013 who came for 
treatment at the Department of O.R.L.H.N.S RSUP Dr. Mohammad Hoesin 
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Palembang. Inclusion criteria are patients initially diagnosed with 
Nasopharyngeal Carcinoma (NPC), NPC patients who have undergone 
radiotherapy, chemotherapy or combination chemoradiotherapy, and 
complete Medical Record. Exclusion Criteria were NPC patients who had 
not received treatment. Sampling in this study was conducted by total 
sampling. The subjects were 52 patients. 
Data was obtained through medical records, such as age, sex, clinical 
stage, T size, N size, histopathology and treatment of patients initially 
diagnosed with NPC from January 2013 until December 2013. Then, the 
patient or family was contacted to find out the patient's last condition 
whether if they survived or died. Univariate analysis was performed on the 
characteristics data of the subjects. 
The data from the univariate analysis were analyzed furtherly using 
survival analysis by the Kaplan Meier method. To test the strength of the 
correlation between the dependent variable (survival rate) with the 
independent variables (age, sex, clinical stage, T size, N size, histopathology 
and therapy), a multivariate analysis was performed. The p value is 
considered significant if P <0.05 with a 95% confidence interval. 
Validation test for factors is considered related in the cox regression 
analysis, if the sensitivity and specificity >80% then these factors are 
considered as valid prognostic factors. Data processing and results using 
SPSS software for Windows version 21.0. Data from the results of statistical 
analysis are displayed in tables, graphs and textures.. 
3. RESULT 
This study was conducted on 52 NPC patients who were initially 
diagnosed from January 2013 until December 2013 in the O.R.L.H.N.S. 
RSUP Dr. Mohammad Hoesin Palembang who met the inclusion and 
exclusion criteriacriteria. 
Table 1. Life Table 
In the first year, subjects who died were 3.8% and survivors were 
96.2%. In the second year, subjects who died became 28.8% and survivors 
became 71.2%. In the third year, subjects who died increased to 36.5% and 
those who experienced survival decreased to 63.5%. In the fourth year the 
subjects who died became 40% and the survivors became 59.6%. In the fifth 
year, 50% of subjects died and 50% experienced survival. The distribution 
of subjects by age found that the age group of more than 50 years was more 
dominant, as many as 21 people. (Table 1, Picture 1). 
Picture 1. Kaplan Meier's For patients with NPC RSUP Dr. Mohammad 
Hoesin based on overall survival rate 
 
 
Overall survival rate based on age, less than 20 years, 20-29 years, 30-
39 years, 40-49 years and more than 50 years respectively 33.3%, 100%, 
30.8%, 54.5% and 52.4%. The distribution of subjects with male more than 
women is 36 people and 16 people with overall survival rate based on male 
and female gender is 47.2% and 56.3%. From this study, it was shown that 
27 NPC patients who came were diagnosed with stage IV. Overall survival 
rate based on clinical stages I, II, III and IV were 66.7%, 66.7%, 46.2% and 
44.4% respectively (table 2). 
Table 2. Distribution of patients based on prognostic factors 
The relationship between age and survival, based on the results of statistical 
analysis  p value is 0.151 (P-value >0.05), meaning no statistical significance. 
This shows that there is no statistically significant relationship between the age 
variable with survival based on life and death groups. The hazard ratio value of 
7.254 shows that death is faster in the age category above 50 years. The 
relationship between sex and survival, based on the results of statistical analysis, 
resulted in a p value is 0.947 (P-value >0.05), meaning not statistical significance. 
This shows that there is no statistically significant relationship between gender 
variables with survival based on life and death group. Based on the hazard ratio 
value of 3,077, it shows that each time of death is faster in the male group 
compared to the female. 
The relationship between stage and survival, the results of statistical analysis 
revealed p value of 0.413 (P-value >0.05), meaning that it was not significant or 
not statistically significant. This shows that there is no statistically significant 
relationship between stage variables with survival based on life and death groups. 
Stage I has a better survival. Based on the value of the hazard ratio, stage IV has 
the highest value of 2,691 each time death is faster at stage IV. 
The relationship between T Size and survival, based on the results of 
statistical analysis p value is 0.020 (P-value <0.05), meaning significant or 
statistically significant. This shows that there is a statistically significant 
relationship between T Size variables with survival based on life and death 
groups. Based on the hazard ratio value of 2,691, it shows that each time of death 
is faster in the group of NPC patients with T4 size. The relationship between N 
size and survival, based on the results of statistical analysis, it is known that p 
value is 0.027 (P-value <0.05), meaning that it is significant or statistically 
significant. This shows that there is a statistically significant relationship between 
N Size variables on survival based on life and death groups. Based on the hazard 
ratio value of 1,474, it shows that death is faster in the NPC group of N2 patients. 
The relationship between Metastasis and survival, based on the results of 
statistical analysis, it is known that the p value is 0.013 (P-value <0.05), meaning 
that it is significant or statistically significant. This shows that there is a 
statistically significant relationship between the Metastasis variable on survival 
based on life and death groups. Based on the value of the hazard ratio of 0.081 
shows that death is faster in the group of NPC patients with Distant Metastasis. 
Time (Year) Cumulative Death (%) Survival rate (%) 
1 3.8 96.2 
2 28.8 71.2 
3 36.5 63.5 
4 40 59.6 
5 50 50.0 
Prognostic Factors n=52 Percentage (%) Survival Rate (%) 
Age 
  <20  
  20-29  
  30-39  
  40-49  
  >50  
 
3 
4 
13 
11 
21 
 
5.8 
7.7 
25 
21.1 
40.4 
 
33.3 
100 
30.8 
54.5 
52.4 
Sex 
   Males 
   Females 
 
36 
16 
 
69.2 
30.8 
 
47.2 
56.3 
Stage  
   Stage I 
   Stage  II 
   Stage  III 
   Stage  IV 
 
3 
9 
13 
27 
 
5.8 
17.3 
25 
51.9 
 
66.7 
66.7 
46.2 
44.4 
T Size 
   T1 
   T2 
   T3 
   T4 
 
5 
12 
15 
20 
 
9.6 
23.1 
28.8 
38.5 
 
60 
58.3 
53.3 
40 
N Size 
   N0 
   N1 
   N2 
   N3 
 
19 
13 
11 
9 
 
36.5 
25 
21.2 
17.3 
 
63.2 
23.1 
63.6 
44.4 
Metastasis 
  M0 
  M1 
 
47 
5 
 
90.4 
9.6 
 
51.1 
40 
Histopathology 
   WHO type I 
   WHO type II 
   WHO type III 
 
3 
16 
33 
 
5.8 
30.8 
63.4 
 
66.7 
50 
48.5 
Therapy 
 Radiotherapy 
Chemoradiotherapy 
 
3 
49 
 
5.8 
94.2 
 
66.7 
48.9 
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 The relationship between the types of histopathology with survival, 
based on the results of statistical analysis known p value of 0.618 (P-value 
>0.05), meaning that it is not significant or statistically significant. This 
shows that there is no statistically significant relationship between 
histopathological type variables on survival based on life and death groups. 
Based on the hazard ratio value of 2,119, it shows that death is faster in the 
group of NPC patients with a hazard ratio value of 2.119 which indicates 
that type I WHO death is faster than WHO type III. The relationship between 
therapy with survival, based on the results of statistical analysis using 
statistical tests known p value of 0.872 (P-value >0.05), meaning that it is 
not significant or statistically significant. This shows that there is no 
statistically significant relationship between therapeutic variables on the 
survival of a statistically significant relationship between therapeutic 
variables on survival based on life and death groups. Based on the hazard 
ratio, chemoradiation therapy has a value of 0.893 times, which indicates 
that each time of death is faster in patients with radiotherapy. (Picture 2) 
 
 
 
 
 
 
 
 
 
 
 
 
(a) Tumor 
 
 
 
 
 
 
 
 
 
 
 
 
(b) Node 
 
 
 
 
 
 
 
(c) Metastasis 
 
 
 
 
 
 
 
 
 
 
 
 
(d) Stage 
Picture 2. Kaplan Meier's For patients with nasopharyngeal carcinoma 
RSUP Dr. Mohammad Hoesin based a. Tumor size, b. nodule size, c. 
metastasis, d. stage  
Multivariate analysis is used to assess the correlation between variables 
with a 5-year survival, in which a P-value for each variable is less than 0.05 
(P<0.05) shows significance or meaningful for each variable by looking at 
the ratio hazard based on statistical analysis. In the second step of 
multivariate analysis, it will be seen that multivariate effects can be 
explained that the variables that most influence the survival of NPC patients 
based on P <0.05 and the sequence of hazard ratio strength are T-size, N-
size and Metastasis with 95% IK. The sensitivity and specificity of the size 
of T2 to T1 were 66.7% and 27.3%, respectively. The sensitivity and 
specificity of T3 size to T1 are 66.7% and 21.4%, respectively. The 
sensitivity and specificity values of T4 to T1 are 85.7% and 27.3%, 
respectively. to T1 are 85.7% and 27.3%, respectively. 
Table 3. Multivariate analysis between independent variables and survival 
 
4. DISCUSSION 
The most dominant patient age variable is the age group of more than 
50 years, as many as 21 people. The results of this study are in line with the 
study conducted by Sukri Rahman et al. (2015) from Andalas University, 
Padang, that the incidence of nasopharyngeal carcinoma began to increase 
after the age of 30 years with the highest peak at the age of 45 - 55 years 
[10]. Ferdinand Maubere's study (2014) at the Sanglah Central General 
Hospital in Denpasar found that of the 68 patient samples obtained by the 
age group with the highest incidence of nasopharyngeal carcinoma was the 
30-50 year age group with a total of 35 people or 51.5%. More men than 
women, with 36 men (69.2%) and 16 women (30.8%). Liu et al found more 
men than women, 70 men (84%) and 13 women (16%). Xiao et al reported 
that there were more men diagnosed with NPC than women, respectively 
213 men (71.2%) and 86 women (28.8%). [11] All of these studies have 
occurred because male lifestyles are different from women, such as smoking 
where the number of smokers in men is higher than in women. [12, 13] 
The most common type of histopathology was WHO type III, 
undifferentiated carcinoma of 33 people (63.4%) compared to WHO types I 
and II. These results are in accordance with Adham et al who reported WHO 
type III was found to be around 85% while WHO type II was found to be 
around 2.3%.  [14] El-Sherbieny et al. reported that type III WHO was more 
dominant than WHO type II, 106 people (67%) and 53 people (33%), 
respectively [15]. All of these studies are due to the most type III WHO in 
Southeast Asia and in other countries with a high incidence of KNF, besides 
that undifferentiated carcinoma is closely related to VEB and the high 
expression of p53 is associated with high tumor cell proliferation [16]. 
The stage IV NPC patients were 27 people  (51.9%) compared to 
stages I, II, and III of 3 (5.8%), 4 (7.7%), 13 (25%), and 11 (21.1%). These 
results are in accordance with the research of Adham et al. That more 
advanced stage NPC cases compared to early stage, 40 cases and 8 cases. 
Liu et al reported that the highest stage IV was 32 people (39%) compared 
to stages I, II, III each with 6 people (7%), 25 people (30%), 20 people 
(24%) [14]. All existing research showed that more NPC patients come at 
an advanced stage [16], this is due to inadequate health services, delays 
in NPC patients coming to the hospital due to lack of knowledge, delays 
in early detection of early symptoms of NPC even by experts because 
NPC has non-typical clinical symptoms, similar to an upper respiratory 
tract infection and on endoscopic examination resembles normal in the 
submucosa in the nasopharynx [17]. 
The relationship between the Size of T, N, and M with survival rate 
found that there was a statistically significant relationship between 
survival of the life and death group [18]. Based on the T size, the higher 
T size the faster the death in the NPC group patients, based on the N size 
also shows the faster mortality in the N2 group, whereas based on 
ariable 
Hazard Ratio P Value 
B Value Exp. B 
 T size 
  TI 
  T2   
  T3 
  T4 
 
 
0.520 
0.765 
2.355 
 
0.020 
0.095 
0.127 
2.691 
N size 
NO 
  N1 
  N2 
  N3 
 
 
0.911 
0.388 
2.090 
 
0.027 
0.402 
1.474 
0.124 
Metastasis 
 M0 
 M1 
 
 
2.516 
 
0.013 
0.081 
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metastasis also shows more deaths in the NPC group with distant 
metastases [18]. Based on the results by Hasanov R et al and El-Sherbieny 
showed that the size of T and N at the time of diagnostic is a poor 
prognosis factor in patients the relationship between therapy with survival 
using a statistical test known p value of 0.872 (P-value >0, 05), the 
meaning is not significant or statistically significant for survival based on 
life and death groups. NPC patients undergoing radiotherapy have a better 
survival than chemoradiation. Kong et al. reported that the 5-year survival 
rate of NPC patients who underwent radiotherapy reached 50%-80%. 
Chua et al. reported that 141 people in stages I and II had very good 
results, 10 years survival rate reaching 98%. [19]. Based on the hazard 
ratio the combination therapy of radiotherapy and chemotherapy has a 
value of 0.893 times which shows that at any time of death faster in 
patients with radiotherapy. Therapy on NPC is given with the aim of 
reducing tumor progressivity. Therapy is also closely related to staging. 
Radiotherapy is a therapeutic modality for NPC at an early stage, whereas 
a combination therapy for radiotherapy and chemotherapy is given at an 
advanced stage. The results of therapy will be bad if the primary tumor is 
large, infiltrative, ulcerative, intracranial extension, large neck tumor, and 
distant metastases. So it can be concluded that survival in NPC patients 
with combination therapy with radiotherapy and chemotherapy will be 
worse than radiotherapy [20]. 
Based on multivariate analysis, the variables that most influence the 
survival of NPC patients based on P-value <0.05 and the order of strength 
of hazard ratios are the categories of size T, size N and then Metastasis with 
95% CI. Based on the results of the validity test of the T size, the highest 
sensitivity value is the sensitivity value of the T4 size to the T1 size that is 
85.7% but the specificity value is only about 27.3%, if the sensitivity and 
specificity >80% then the factor is considered a prognostic factor valid, so 
the T size factor in this study cannot be considered as a valid prognostic 
factor because of the low specificity value. 
There are limitations in this study, such as data from the medical record 
did not get comorbid disease in NPC patients which can aggravate general 
conditions such as diabetes, hypertension, and myocardial infarction. 
Another limitation is the limited number of NPC patient samples that can 
have an impact in analyzing data on morbidity and mortality 
5. CONCLUSION 
Prognostic factors that affected the survival rate of NPC patients in 
RSUP. Dr. Mohammad Hoesin Palembang is a category of size T, N, and 
Metastasis. Suggestions need to be carried out study regarding the survival 
rate of NPC patients with a larger number of samples and follow-up within 
a period of 5 years. 
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